Updated:
Receptive Capital
Receptive Capital invests in and supports the legal cannabis industry through principal investments, syndicated investments, and advisory services.
Receptive Capital
Receptive Capital invests in and supports the legal cannabis industry through principal investments, syndicated investments, and advisory services. It provides investment and advisory support for early stage cannabis companies, including licensing project management, business plan development, growth strategy, fundraising, and due diligence. Its focus includes East coast markets in the US across brands, technology, and science at Pre-Seed, Seed and Series A stages.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
North America
Country
United States
City
Woodbury
Corporate office
Woodbury, NY, United States
Sector focus
Frequently asked questions
How does Receptive Capital source its investment opportunities?
The firm states that a syndicate lead sources and conducts due diligence on each deal, delivering what it describes as highly vetted opportunities to syndicate members. No specific sourcing channels, proprietary networks, or external relationships are disclosed.
Is Receptive Capital structured as a fund or a deal-by-deal syndicate?
Receptive Capital operates as a deal-by-deal syndicate. It does not require capital commitments from participants. Members choose which individual investments to make, with minimums as low as $5,000, which the firm contrasts with the $50,000-to-$100,000 minimums it cites as typical for early-stage cannabis deals.
What investment stage does Receptive Capital target?
The firm focuses on early-stage cannabis companies, specifically seed and startup stages. Its website and research record both classify the strategy as early-stage, and its advisory services are built around business-plan development and licensing project management, which supports pre-revenue and newly licensed operators.
Does Receptive Capital participate in fund commitments or only direct deals?
Receptive Capital does not appear to make fund commitments. Its disclosed structure is limited to direct principal investments and syndicated deals on an individual, deal-by-deal basis. No fund-of-funds activity or LP commitments to external managers are mentioned.
Where does the firm focus geographically within the cannabis industry?
The firm targets the US legal cannabis market, with explicit emphasis on East Coast expansion. Its materials cite densely populated Eastern states, interstate travel dynamics, and the regulatory learning curve from Western states as drivers of that focus. No international activity is disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: